Daxxify 100 UNT Injection
- RxCUI
- 2612456
- RxNorm name
- Daxxify 100 UNT Injection
- Display name
- Daxxify 100 UNT Injection
- Full name
- Daxxify 100 UNT Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761127 | Daxxify | daxibotulinumtoxinA-lanm | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAXXIFY | BOTULINUM TOXIN TYPE A | Revance Therapeutics, Inc. | 3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 2612456 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74 | Daxxify 100 UNT Injection | SY | 12 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | 20260107 |
| 3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74 | daxibotulinumtoxinA-lanm 100 UNT Injection [Daxxify] | SBD | 12 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | 20260107 |
| 3aaa6e14-a3f7-4fb2-b9f9-d3a9c3ae1f74 | Daxxify 100 UNT Injection | PSN | 12 | These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | 20260107 |